Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 178 member B pseudogene (also known as LOC100421548, ENSG00000271003) is classified as a pseudogene, and as such, it does not code for a functional protein product[1][3]. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional; they are usually considered remnants of genes that have lost their ability to encode protein due to mutations or evolutionary processes[1][3]. No functional protein, biological activity, or clinical targeting is associated with this pseudogene. Thus, it is not considered a therapeutic target or receptor, and no disease associations, known functions, or drug interactions are reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 178 member B pseudogene.